mail
editor@ajptr.com
whatsapp
9409046853
logo

American Journal of PharmTech Research

S. Parthiban

Author Profile
2
Publications
1
Years Active
5
Collaborators
53
Citations

Publications by S. Parthiban

2 publications found • Active 2016-2016

2016

2 publications

Method Development and Validation of Clobazam In Bulk and Pharmaceutical Dosage Forms by Using RP-HPLC Method

with Senthilkumar GP1* Parag. S. Mahadik, T. Tamizhmani
6/1/2016

Clobazam is an antiepileptic drug. There have been very less number of analytical methods developed for estimation of Clobazam in pure bulk form and in dosage form. In the present research a simple, accurate, precise and cost effective High performance liquid chromatographic method for the estimation of Clobazam, in bulk and pharmaceutical dosage form was carried out. HPLC method was developed on a Symmetry C-8 (4.6×150mm), 3.5µm particle, reversed-phase column. The mobile phase was acetonitrile: phosphate buffer (0.05M, pH- 4.5), 60:40 (v/v) at a flow rate of 0.8ml/min. The eluate was monitored at 231 nm. The method was validated reaching satisfactory results for selectivity, precision and accuracy. The retention time of the drug was found to be 3.38min in the mobile phase, acetonitrile: 0.05M potassium dihydrogen orthophosphate buffer (pH-4.5) 40: 60 (v/v). A linear response was observed in the range of 20-60µg/ml with a regression coefficient of 0.999. Validation parameters were carried out as per the guidelines of International Conference for Harmonization (ICH). This method can be used in the industries for determination of Clobazam to analyze the quality of formulation without interference of the excipients.

Evaluation of Anti Bacterial Efficacy of Chitosan Loaded Levofloxacin Nanoparticle Prepared By Emulsion Solvent Diffusion Method

with Nishanth Kumar, G.P Senthil Kumar, T. Tamizh Mani
6/1/2016

The aim of the present study was an attempt to formulate and evaluate Levofloxacin loaded chitosan nanoparticles (CS-NP) by Emulsion solvent diffusion method using poloxamer 188 as surfactant; about eight different formulations (F1-F8) were prepared by changing the ratios of drug and excipients . Among all the formulations F3 was selected as optimized formulations  based on the physico chemical parameters and drug release studies and  it was incorporated in to 1% W/W of Carbopol gel (GF3) to obtained ophthalmic gel ,further, it was evaluated for antimicrobial activity against S. aureus and Bacillus subtilis. Compatibility studies by FT-IR showed no significant interactions between drug and excipients. The prepared Chitosan nanoparticle were characterized for different parameters like particle size analysis, zeta measurement, SEM, % drug content, entrapment efficiency, FT-IR, DSC, In-vitro release. The Gel containing chitosan nanoparticles (GF3)  were evaluated for different parameters like physical examination, pH, spread ability, viscosity, reological property, % drug content and  In-vitro release. The in vitro dug release and antimicrobial efficacy of GF3 formulation was compared with marketed product. From the results it was observed that the formulation controlled the drug release over a period of 24 hrs following Higuchi model and nonfickian diffusion mechanism with better antimicrobial action than the marketed product. The ocular irritancy study confirmed that ther is no irritation to the eye. From the above study we can conclude that the Levofloxacin loaded CS-NP were successfully prepared by emulsion solvent diffusion method and it is found to be  suitable for sustained ocular drug delivery having improved antibacterial action.

Whatsapp